Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nathan Fisher

Hand Surgery Saint Louis, MO Doctor of Osteopathy

NPI 1003231853 CMS profile 1398556

12639 Old Tesson Rd Ste 115, Saint Louis, MO 63128

Open in the dashboard

General payments

$9,844

84 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nathan Fisher of Saint Louis, MO is reported in the CMS Open Payments database as having received $9,844 across 84 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $166 8
2024 General $890 10
2023 General $336 7
2022 General $46 3
2021 General $4,987 19
2020 General $279 6
2019 General $3,140 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nathan Fisher
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Nathan Fisher were reported at $166. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Nathan Fisher Hand Surgery median Middle half National median
2019 $3,140 $383 $106–$1,905 $163
2020 $279 $172 $51–$1,268 $114
2021 $4,987 $263 $71–$1,591 $132
2022 $46 $336 $87–$1,938 $149
2023 $336 $233 $81–$1,114 $160
2024 $890 $258 $88–$1,203 $164
2025 $166 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $3,047 9 payments
  2. Elite Orthopedics, LLC $2,145 15 payments
  3. Medical Device Business Services, Inc. $1,464 11 payments
  4. Sonex Health, Inc. $791 7 payments
  5. Zimmer Biomet Holdings, Inc. $742 7 payments
  6. Endo Pharmaceuticals Inc. $422 7 payments
  7. Skeletal Dynamics Inc $366 3 payments
  8. Stryker Corporation $234 6 payments
  9. KCI USA, Inc $103 1 payment
  10. Medtronic USA, Inc. $99 2 payments
  11. Other $432 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $3,600 3 payments
  2. Food and Beverage $3,508 72 payments
  3. Travel and Lodging $2,736 9 payments
Products named General payments · program years 2019–2025
  1. VA-LCP PLATES & SCREWS $1,464 11 payments
  2. SX-One Microknife $791 7 payments
  3. XIAFLEX $462 9 payments
  4. Biowick $444 3 payments
  5. Geminus $366 3 payments
  6. Align $366 3 payments
  7. IJS $366 3 payments
  8. IMPlate $366 3 payments
  9. Trauma Product Portfolio $144 1 payment
  10. Hips Product Portfolio $119 1 payment
  11. Other $886 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

183

Median for Orthopedic Surgery: 203

Drug cost

$161,896

Median for Orthopedic Surgery: $1,433

Branded share of claims

66.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xiaflex Collagenase Clostridium Hist. Brand 15 $161,030
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 90 $494
Methylprednisolone Generic 33 $194
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 17 $79
Cephalexin Generic 12 $61
Meloxicam Generic 16 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 101 billing codes

Paid by Medicare

$131,946

Of which drugs: $2,061

Medicare patients

423

Average age 74

Services billed

1,685

246 women, 177 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Ischemic heart disease 33%
Depression 32%
Diabetes 29%
Chronic kidney disease 27%
Heart failure 20%
Osteoporosis 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 135 406 $2,033

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

84 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record